Detalhe da pesquisa
1.
Angiotensin II receptor inhibition ameliorates liver fibrosis and enhances hepatocellular carcinoma infiltration by effector T cells.
Proc Natl Acad Sci U S A
; 120(19): e2300706120, 2023 05 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-37126700
2.
Development of a Novel Comprehensive Hepatocellular Carcinoma Outcome Prognostic Scoring System With Integration of Imaging Features.
Oncologist
; 2023 Dec 30.
Artigo
em Inglês
| MEDLINE | ID: mdl-38159256
3.
Clinical and Prognostic Biomarker Value of Blood-Circulating Inflammatory Cytokines in Hepatocellular Carcinoma.
Oncology
; 101(11): 730-737, 2023.
Artigo
em Inglês
| MEDLINE | ID: mdl-37467732
4.
Progression patterns and therapeutic sequencing following immune checkpoint inhibition for hepatocellular carcinoma: An international observational study.
Liver Int
; 43(3): 695-707, 2023 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-36577703
5.
HepatoScore-14: Measures of Biological Heterogeneity Significantly Improve Prediction of Hepatocellular Carcinoma Risk.
Hepatology
; 73(6): 2278-2292, 2021 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-32931023
6.
Plasma Growth Hormone as a Prognostic Biomarker to Durvalumab and Tremelimumab in Patients with Advanced Hepatocellular Carcinoma.
J Hepatocell Carcinoma
; 11: 455-461, 2024.
Artigo
em Inglês
| MEDLINE | ID: mdl-38463542
7.
Individual ingredients of NP-101 (Thymoquinone formula) inhibit SARS-CoV-2 pseudovirus infection.
Front Pharmacol
; 15: 1291212, 2024.
Artigo
em Inglês
| MEDLINE | ID: mdl-38379905
8.
Angiotensin II receptor inhibition ameliorates liver fibrosis and enhances hepatocellular carcinoma infiltration by effector T cells.
bioRxiv
; 2023 Mar 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-36945365
9.
The Gut Microbiome as a Biomarker and Therapeutic Target in Hepatocellular Carcinoma.
Cancers (Basel)
; 15(19)2023 Oct 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-37835569
10.
Outcomes of beta blocker use in advanced hepatocellular carcinoma treated with immune checkpoint inhibitors.
Front Oncol
; 13: 1128569, 2023.
Artigo
em Inglês
| MEDLINE | ID: mdl-36865801
11.
The Prognostic Value of Baseline Clinical and Radiologic Imaging Features in Patients with Unresectable Hepatocellular Carcinoma Treated with Atezolizumab Plus Bevacizumab.
J Hepatocell Carcinoma
; 9: 913-927, 2022.
Artigo
em Inglês
| MEDLINE | ID: mdl-36065424
12.
Blockade of growth hormone receptor signaling by using pegvisomant: A functional therapeutic strategy in hepatocellular carcinoma.
Front Oncol
; 12: 986305, 2022.
Artigo
em Inglês
| MEDLINE | ID: mdl-36276070
13.
Plasma growth hormone is a potential biomarker of response to atezolizumab and bevacizumab in advanced hepatocellular carcinoma patients.
Oncotarget
; 13: 1314-1321, 2022 12 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-36473155
14.
A Randomized, Double-Blind, Placebo-Controlled, Multicenter Study to Evaluate the Safety and Efficacy of ThymoQuinone Formula (TQF) for Treating Outpatient SARS-CoV-2.
Pathogens
; 11(5)2022 May 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-35631072
15.
Perioperative nivolumab monotherapy versus nivolumab plus ipilimumab in resectable hepatocellular carcinoma: a randomised, open-label, phase 2 trial.
Lancet Gastroenterol Hepatol
; 7(3): 208-218, 2022 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-35065057
16.
Current Landscape and Future Directions of Biomarkers for Immunotherapy in Hepatocellular Carcinoma.
J Hepatocell Carcinoma
; 8: 1195-1207, 2021.
Artigo
em Inglês
| MEDLINE | ID: mdl-34595140
17.
The Impact of Angiotensin-Converting Enzyme 2 (ACE2) Expression on the Incidence and Severity of COVID-19 Infection.
Pathogens
; 10(3)2021 Mar 22.
Artigo
em Inglês
| MEDLINE | ID: mdl-33809851
18.
Insulin-like growth factor 1/Child-Turcotte-Pugh composite score as a predictor of treatment outcomes in patients with advanced hepatocellular carcinoma treated with sorafenib.
Oncotarget
; 12(8): 756-766, 2021 Apr 13.
Artigo
em Inglês
| MEDLINE | ID: mdl-33889299
19.
A Prospective Phase II Study of Safety and Efficacy of Sorafenib Followed by 90Y Glass Microspheres for Patients with Advanced or Metastatic Hepatocellular Carcinoma.
J Hepatocell Carcinoma
; 8: 1129-1145, 2021.
Artigo
em Inglês
| MEDLINE | ID: mdl-34527608